The Captopril Prevention Project, Further Analyses on Left Ventricular Hypertrophy and Diabetes

Author： Himmelmann Anders   Hansson Lennart   Hedner Thomas  

Publisher： Informa Healthcare

ISSN： 0803-7051

Source： Blood Pressure, Vol.10, Iss.2, 2001-04, pp. : 60-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regression of Chronic L -NAME-Treatment-induced Left Ventricular Hypertrophy: Effect of Captopril

By Bernátová I.       Pelouch V.   Šimko F.  

Journal of Molecular and Cellular Cardiology, Vol. 32, Iss. 2, 2000-02 ,pp. : 177-185

Academic Press

Access to resources Recommend Favorite

Myocardial Energetics in Left Ventricular Hypertrophy

By  

Current Cardiology Reviews, Vol. 5, Iss. 3, 2009-08 ,pp. : 243-250

Bentham Science Publishers

Access to resources Recommend Favorite

Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure

By Derosa Giuseppe   Maffioli Pamela  

Expert Review of Cardiovascular Therapy, Vol. 11, Iss. 6, 2013-06 ,pp. : 719-728

Informa Healthcare

Access to resources Recommend Favorite

Prevalence of Left Ventricular Hypertrophy and Determinants of Left Ventricular Mass in Obese Women

By Salvetti Guido  

High Blood Pressure & Cardiovascular Prevention, Vol. 19, Iss. 1, 2012-03 ,pp. : 33-39

Adis International

Access to resources Recommend Favorite

Hypertensive Left Ventricular Hypertrophy: Pathophysiological and Clinical Issues

By Agabiti-Rosei Enrico   Muiesan Maria Lorenza  

Blood Pressure, Vol. 10, Iss. 5-6, 2001-11 ,pp. : 288-298

Informa Healthcare

Access to resources Recommend Favorite